Bringing ADHD medication to Spain: the controlled-medicine route

Spain has one rule for ordinary prescription medicines and another for controlled ones. The Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) sets out the general position on its page about medicines intended for the treatment of travellers, last updated 28 May 2026, and then carves out narcotics and psychotropics, directing travellers to a separate procedure.

Common stimulant treatments for ADHD sit in that carved-out group, as do strong opioid painkillers and a number of sedatives. Which specific products are classified as narcotics or psychotropics is a legal classification rather than something you can read off the box, so confirm your own medicine with your prescriber and, where there is any doubt, with AEMPS directly before you book flights.

The practical difference matters. For an ordinary prescription medicine, the paperwork is something you carry. For a controlled medicine, the paperwork is something you have to obtain in advance from a named part of AEMPS, and that takes calendar time you need to build into a relocation schedule.

AEMPS publishes the procedure on its estupefacientes y psicótropos pages, which carried a last-updated date of 27 May 2026 when we read them. For a traveller entering Spain, AEMPS states that the request is made by email to its dedicated address for travellers carrying controlled medicines, and it names the fields the request must contain:

• the country of origin and the duration of the trip, with start and end dates
• the patient's name, surnames, identity or passport number, and date and place of birth
• the prescribing doctor's name, surnames, professional registration number, practice, address and telephone number
• the medicine's brand name, presentation and dosage

AEMPS states that the request must be accompanied by documentation evidencing the need for the treatment and the prescribed daily doses. It states a maximum of three months of treatment for entry, and that the permit is valid for a maximum of three months.

Because everything on that list comes from your prescriber rather than from you, the sensible order is to ask your doctor for a detailed treatment letter first, then submit. AEMPS does not publish a processing time on the pages we read, checked 7 August 2026, so treat the application as something to start weeks ahead of departure rather than days. If your dates change, the trip duration and the permit validity are both tied to what you submitted.

The reverse direction has its own route, and it is worth knowing before your first trip home. AEMPS states that a traveller leaving Spain requests a certificate authorising the transport, applied for through the LABOFAR platform accessible from the AEMPS electronic office, and that the applicant may be the patient, the prescribing doctor or a drug-dependency treatment centre.

AEMPS states that the certificate covers a maximum of 30 days of medicine, with exceptions noted for anticonvulsant agents or where the destination country's own rules permit longer. It states that the certificate is valid until the day after the planned return date, and that where the trip exceeds 30 days the validity is limited to 30 days from departure. AEMPS also states that a medical certificate or report must be attached where the destination is not a signatory to the Schengen Agreement, or where the request comes directly from the patient.

Read those two limits together and a pattern appears. Coming into Spain, AEMPS works in three-month blocks. Going out of Spain, it works in 30-day blocks. A family that assumes symmetry between the two will get the outbound trip wrong.

Search results on this topic are dominated by the Schengen certificate, and it is frequently presented as the answer for anyone moving to Spain with ADHD medication. It is not.

Article 75 of the Convention Implementing the Schengen Agreement provides a certificate that lets a patient carry prescribed controlled medicines when travelling between Schengen countries. Germany's Federal Institute for Drugs and Medical Devices (BfArM) publishes a clear English explainer on travelling with narcotic drugs, which states that the certificate is valid for a maximum of 30 days, that a separate certificate is needed for each controlled drug, that it is completed by the treating physician, and that it must be authenticated by the competent health authority before travel. For destinations outside the Schengen Area, BfArM describes a different document instead: a multilingual certificate stating the individual and daily dosage, the international name of the active substance and the duration of the journey, also authenticated by the health authority.

Three consequences follow for a family relocating from the United States or the United Kingdom. Flying in from a non-Schengen country is not an Article 75 journey, so the AEMPS entry permit is the instrument that applies. Article 75 becomes relevant later, for weekend trips from Spain to France or Italy once you live there. And in every case it is a 30-day travel document, which means it does not solve an ongoing prescription. The answer to an ongoing prescription is a Spanish one.

The permit gets your existing supply across the border. It does nothing for month four. Getting onto a Spanish prescription is the part of this that deserves the most planning, and it is best started in your first fortnight rather than when the box is nearly empty.

Two things commonly slow it down. The first is that controlled medicines are prescribed under a tighter regime everywhere in Europe, which usually means an in-person assessment and often a specialist rather than a family doctor. Bring the full clinical history, not just the current prescription: the original diagnostic assessment, the dose history, and anything documenting why alternatives were changed or stopped.

The second is product availability. If the exact formulation you take is not marketed in Spain, AEMPS operates a separate route. Its page on medicamentos extranjeros, published 12 June 2023, states that the Agency may exceptionally authorise access to medicines not authorised in Spain, that hospital requests are made by the hospital pharmacy service, and that for outpatient dispensing the patient attends a foreign-medication contact point with a medical report. AEMPS also notes on its traveller pages that each autonomous community has contact points for information about centres authorised to dispense foreign medicines, so the operational detail is regional even though the authorisation is national. Ask your Spanish doctor about this at the first appointment.

Anyone arriving on a Spanish long-stay visa has a period before public entitlement is settled, and for non-working arrivals that period can be long. Private health cover carries the medical risk across it. For a household with a controlled prescription, there are two parts of the policy worth reading closely and one expectation worth resetting.

The first part is outpatient prescription medicines. Private policies are built mainly around consultations, diagnostics and hospital treatment, and the cost of drugs collected from a pharmacy is often handled separately from the consultation that produced the prescription. Check whether outpatient pharmacy appears in the schedule of benefits at all, and what annual limit sits against it.

The second is how pre-existing conditions are treated, since a diagnosis you already hold when the policy starts is handled differently from one that arises later, and the medicines attached to it follow that treatment. The expectation to reset is this: no insurance policy, public or private, changes the controlled-medicines rules. The AEMPS permit, the border paperwork and the need for a Spanish prescriber apply regardless of how you are covered. Read the schedule of benefits and the exclusions for the two points above, and treat the medication route as a separate workstream from the cover.